MiMedx GroupMDXG.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, MiMedx Group (MDXG.O) trades at a P/E of 104.00x, P/B of 3.00x, P/S of 1.82x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 95th percentile over the trailing 10Y window (vs. 95th percentile over 3Y); P/B sits at the 15th percentile over the trailing 10Y window (vs. 17th percentile over 3Y); P/S sits at the 25th percentile over the trailing 10Y window (vs. 19th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 92nd percentile within its industry and the 94th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.48%, ranking at the 59th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 80.4 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. MiMedx Group operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: MDXG · MDXG
Want the full picture on whether MiMedx Group (MDXG.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 104.00 | ||||||
| P/B (MRQ) | 3.00 | ||||||
| P/S (TTM) | 1.82 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.48% |